Table 7 |
|||||
|
Percentage (95% CI) of respondents rating each type of medication as "harmful" for the person described in the vignette |
|||||
|
Medication |
Country |
Depression Vignette |
Depression/Suicidal Vignette |
Early Schizophrenia Vignette |
Chronic Schizophrenia Vignette |
|
|
|||||
|
Vitamins, minerals |
Australia |
4.4 (2.9–6.7) |
5.4 (3.7–7.9) |
5.8 (4.1–8.4) |
6.4 (4.5–9.0) |
|
Japan |
14.6 (11.5–17.7) |
13.8 (10.8–16.8) |
14.6 (11.5–17.7) |
14.8 (11.7–17.9) |
|
|
Pain relievers |
Australia |
37.7 (33.0–42.6) |
37.3 (33.1–41.7) |
38.9 (34.6–43.4) |
34.5 (30.0–39.3) |
|
Japan |
43.4 (39.0–47.8) |
42.6 (38.3–46.9) |
36.6 (32.4–40.8) |
35.6 (31.4–39.8) |
|
|
Antidepressants |
Australia |
27.5 (23.5–31.8) |
23.4 (19.8–27.4) |
22.6 (19.2–26.5) |
29.3 (25.2–33.8) |
|
Japan |
18.2 (14.8–21.6) |
21.2 (17.6–24.8) |
15.2 (12.0–18.4) |
10.6 (7.9–13.3) |
|
|
Antibiotics |
Australia |
38.3 (33.4–43.4) |
37.8 (33.0–42.8) |
35.9 (31.5–40.4) |
36.9 (32.4–41.7) |
|
Japan |
29.8 (25.8–33.8) |
37.6 (33.3–41.9) |
29.0 (25.0–33.0) |
22.8 (19.1–26.5) |
|
|
Sleeping pills |
Australia |
49.6 (44.9–54.3) |
50.3 (45.9–54.7) |
53.1 (48.2–57.9) |
58.8 (54.3–63.1) |
|
Japan |
27.0 (23.1–30.9) |
27.8 (23.9–31.7) |
30.0 (26.0–34.0) |
27.0 (23.1–30.9) |
|
|
Antipsychotics |
Australia |
48.3 (43.5–53.1) |
40.4 (35.9–45.0) |
24.5 (20.6–28.8) |
24.5 (20.9–28.5) |
|
Japan |
19.0 (15.5–22.5) |
23.8 (20.1–27.5) |
17.4 (14.1–20.7) |
8.4 (6.0–10.8) |
|
|
Tranquillizers |
Australia |
60.4 (55.8–64.8) |
60.1 (55.5–64.5) |
47.5 (42.9–52.2) |
55.7 (50.9–60.4) |
|
Japan |
15.8 (12.6–19.0) |
17.6 (14.3–20.9) |
13.4 (10.4–16.4) |
9.4 (6.8–12.0) |
|
|
|
|||||
|
Jorm et al. BMC Medicine 2005 3:12 doi:10.1186/1741-7015-3-12 |
|||||
